Expression of genes in eukaryotes has commonly been analyzed in a whole tissue, and levels ofexpression have been interpreted as the result of equivalent rates of transcription in every cell. We have produced transgenic mouse lines that express 18-galactosidase under the control of globin promoters linked to the major tissue-specific regulatory element of the a-globin locus, which permits the analysis of transgene expression in individual red blood cells. We find that expression of the transgene within all mouse lines is heterocellular. Individual cells either do not express the transgene at all or express it at a level characteristic of that line. The number of 18-galactosidase-expressing cells varies greatly between different lines of transgenic mice at any defined stage of development, but within a transgenic line, individual mice have strikingly similar numbers of expressing cells. This suggests that the degree of heterocellular expression is determined by the site of integration, as is seen in position-effect variegation.
The possibility that transgenes may be expressed in a mosaic pattern is rarely considered. Traditionally, expression of globin transgenes is analysed by lysis and extraction of mRNA from erythroid cells, and measurements are taken to be representative of expression levels in all cells. Expression levels determined for different transgenes, or at different developmental stages, are thus interpreted as the result of an equivalent rate of transcription in every cell. However, such differences could also arise from changes in the proportion of cells expressing the gene, which would not be evident when cells were examined as a group. It is commonly assumed that within a given tissue, each cell transcribes a transgene, but this has been shown not to be true in several studies (1) (2) (3) (4) (5) (6) (7) (8) . Inactivation of a gene in varying numbers of cells upon integration near inactivating chromatin has been described in Drosophila (9) and yeast (10) and termed position-effect variegation. The behavior of transgenes may resemble this phenomenon.
The individual globin genes are poorly expressed in transgenic mice when linked only to their promoters. However, when also linked to sequences associated with four DNase I hypersensitive sites located 6-18 kb upstream of the 13-globin structural genes, termed the 13-globin locus control region (13 LCR), levels of expression similar to the endogenous mouse globin genes are observed. All lines give high levels of expression, and these levels are copy number dependent, indicating that each copy of the transgene is independently expressed (11, 12) . A regulatory element located 40 kb upstream of the a-globin locus (aHS-40) is similar to the 1 LCR in that it gives high levels of erythroid-specific expression in cell culture (13) and transgenic mice (14-16) regardless of integration site; however, expression of an a-globin gene linked to alHS40 declines
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with development (15, 16) and is not copy number dependent (14) (15) (16) (17) .
We have generated transgenic mouse lines using globin promoter-aHS-40 constructs linked to the Escherichia coli lacZ gene rather than a globin structural gene. Histochemical staining for 13-galactosidase (13-gal) activity provides a simple cell-by-cell assay for transgene expression in individual erythrocytes. We find that the transgene is expressed in a heterocellular pattern. Furthermore, the number of 13-gal-expressing cells varies greatly between different transgenic lines derived from the same construct but is consistent within a line. Our analysis suggests that variation-in total transgene activity between lines is mainly due to differences in the number of cells committed to transgene expression rather than different levels of promoter activity. It also implicates position effects from the site of transgene integration in determining the degree of heterocellular expression.
MATERIALS AND METHODS
Transgene Constructs. The globin promoter-lacZ-aHS-40 constructs were similar to that used previously (18) , except that the globin promoters were synthesized by PCR amplification.
The 127-bp C promoter was from +6 to -127, and the C/ y hybrid promoter had the same sequence but with bases -83 to -112 replaced by bases -134 to -193 of the 'y promoter, thereby exchanging the regions containing the GATA and CACC motifs of the two promoters; the sequences were confirmed by the Sanger method. Prior to microinjection, DNA fragments were excised from vector sequences with Not I and Kpn I and purified by agarose gel electrophoresis.
Transgenic Mouse Production. Transgenic mice were generated by microinjection into the pronuclei of fertilized eggs from the outbred P.O. mouse strain. Transgenic progeny were identified, and copy number was determined by standard Southern blot analysis of tail DNA. Hemizygous lines were established by mating transgenic founders to P.O. mice.
18-gal Activity in Whole Cells. Twelve and one-half-day embryos were obtained from P.O. females mated with hemizygous transgenic males. After bleeding whole embryos with intact yolk sacs into PBS, erythrocytes were gently pelleted in a microcentrifuge and fixed, washed, and stained with 5-bromo-4-chloro-3-indolyl ,B-D-galactopyranoside (X-Gal) as described (18) for at least 24 h at 37°C. Adult red blood cells obtained by tail bleeding hemizygous transgenic mice 3 months of age or older were similarly stained with X-Gal.
P-gal Activity in Lysates. Transgene activity was determined using lysates of 12.5-day postcoitum (dpc) blood. Twelve and one-half-day embryos obtained from P.O. females mated with hemizygous transgenic males were bled individually into 200 ,ul Abbreviations: 3 LCR, f-globin locus control region; aHS-40, regulatory element located 40 kb upstream of the a-globin locus; 3-gal, 13-galactosidase; X-Gal, 5-bromo-4-chloro-3-indolyl 13-D-galactopyranoside; dpc, day(s) postcoitum.
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Proc. NatL Acad ScL USA 92 (1995) of PBS, and the blood cells from positive embryos (determined by X-Gal staining of 20 ,u of this suspension) were pooled. After counting the pooled cells on a hemocytometer, the cells were spun for 30 s in a microcentrifuge at 4°C and were resuspended in 100 ,1. of ice-cold 250 mM Tris (pH 7.4). The cells were lysed by four cycles of freeze-thawing, and the cellular debris was removed by centrifugation at 4°C for 10 min in a microcentrifuge. One microliter of the resulting lysate was assayed for ,B-gal activity using the substrate o-nitrophenyl ,B-D-galactopyranoside as described (19) with the absorbance of the samples determined at 413 nm.
RESULTS
High-level, erythroid-specific expression of the lacZ gene under the control of the {-globin promoter and the aHS-40 has been reported (18) . In this study, transgenic lines generated with a C/y hybrid promoter give similar patterns of expression.
Analysis of erythroid cell lysates revealed 1-gal activity in all lines tested at 12.5 dpc (Table 1 ), but 13-gal was below detectable levels in lysates from adult mice for 9 of 11 lines (data not shown). This suggests that the embryonic/fetal promoter in the majority of these lines is being developmentally regulated. In the previous study with the 550-bp C promoter alone, a group of 5 lines all showed clear developmental regulation (18) . Subsequently, however, a new line generated with this construct also showed significant expression in adult blood.
When peripheral blood from embryos at 12.5 dpc and adult mice hemizygous for the transgene was stained with X-Gal, it was found that not all cells express 13-gal and that there was a marked variation between transgenic lines in the percentage of expressing cells (Fig. la) (Table 1) .
A possible explanation for this variation is that the promoter is in fact active in all blood cells but at different levels in each line, resulting in different starting concentrations of 13-gal protein, and that the 13-gal activity decays to an undetectable level in some cells as they circulate. To ensure that the numbers observed were not an underestimate, whole cells were stained continuously for extended periods. A plateau in the number of stained cells is reached in both high and low percentage lines between 5 and 20 h (Fig. 2a) , whereas 3-gal activity in lysates from the same cells is constant up to 30 h (Fig. 2b) expression in a pattern typical of each integration site. Assaying transgene expression in individual cells revealed that this variation was mainly due to differences in the number of cells expressing the transgene rather than in the promoter activity within all cells. Other work suggests that this phenomenon is not confined to lacZ constructs or erythroid cells. Heterocellular expression was observed in mice carrying human and murine f3 LCR elements linked to human globin genes (20, 21 (22) (23) (24) .
Position-effect variegation has been intensively studied in Drosophila (9) and yeast (10). Differences in both expression level and silencing are observed when genes are moved to new positions in the genome, presumably due to the influence of flanking heterochromatin or compacted centromeric DNA. In their normal context, similar influences may act on genes to produce the typical pattern and level of expression. Tandem arrays of an integrated construct may undergo heterochromatinization (25) , and thus the differences that we have observed between lines may be due to both different copy numbers and distinct integration sites. Chromatin in the differentiating erythrocyte is compacted (26) like that in regions associated with variegation in yeast and Drosophila and also the entire inactive X chromosome, which has this effect in mammals (27) 
